Description
Taficita Tablets – Tenofovir Alafenamide 25 mg + Emtricitabine 200 mg
Taficita is a fixed-dose combination of Tenofovir Alafenamide (TAF) 25 mg and Emtricitabine 200 mg, used in the treatment and prevention of HIV-1 infection. This combination is commonly prescribed as part of antiretroviral therapy (ART) or pre-exposure prophylaxis (PrEP) for individuals at high risk of HIV exposure. Taficita offers improved kidney and bone safety compared to older tenofovir formulations (TDF).
Key Benefits:
- Used in combination with other ARVs for HIV-1 treatment
- Can be used for daily PrEP to prevent HIV in at-risk individuals
- New-generation tenofovir with better renal and bone safety profile
- Once-daily oral dosing
- Approved and recommended by WHO and national HIV guidelines
How to Use:
Take one tablet orally, once daily with or without food. Always follow your doctor’s prescription and do not discontinue unless advised.
Who Should Use:
- Adults and adolescents (≥12 years, ≥35 kg) with HIV-1 infection
- HIV-negative individuals for PrEP after testing negative
- Not suitable for: those with known hypersensitivity to any component
Possible Side Effects:
- Common: headache, nausea, fatigue, diarrhea
- Less common: increased liver enzymes, insomnia, rash
- Serious (rare): kidney issues, lactic acidosis, liver inflammation
Drug Interactions:
Inform your doctor if you’re taking anticonvulsants, antituberculosis medications, or hepatitis treatments. Avoid combining with TDF-containing medications.
Storage Instructions:
Store at room temperature (15–30°C). Protect from moisture and direct sunlight. Keep out of reach of children.
Frequently Asked Questions (FAQs)
1. What is Taficita used for?
It is used to treat HIV-1 infection in combination with other antiretrovirals, and as PrEP to prevent HIV in high-risk HIV-negative individuals.
2. How is TAF different from TDF?
TAF (Tenofovir Alafenamide) is a newer formulation that is safer for the kidneys and bones compared to TDF (Tenofovir Disoproxil Fumarate).
3. Can Taficita be used alone?
No. It must be used in combination with other ARVs for HIV treatment. As PrEP, it may be used alone after HIV-negative confirmation.
4. Do I need to take Taficita with food?
It can be taken with or without food. However, consistent daily dosing is important for effectiveness.
5. Is it safe during pregnancy?
Taficita may be used in pregnancy if prescribed by your doctor. Inform your provider if you are pregnant or breastfeeding.
6. Can I stop taking Taficita if I feel better?
No. Stopping medication can lead to viral resistance or increased HIV transmission risk. Always consult your doctor first.
